在小鼠中,E3泛基因结合酶Cul5调节了造血干细胞功能,用于稳定状态的造血
Siera A Tomishima1, Dale D Kim1, Nadia Porter2
1Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
The Journal of clinical investigation
|June 26, 2025
概括
库林5 (CUL5) 调节了造血干细胞 (HSC) 的命运. 在小鼠中,CUL5的丧失导致异常的血细胞产生,可以通过JAK1/2抑制来纠正,揭示CUL5.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 造血干细胞 (HSC) 的自我更新和分化对于血液生产至关重要.
- 由细胞因子信号调节的JAK/STAT通路控制HSC的增殖和分化.
- 诸如Cullin 5 (CUL5) 等E3泛素酶通过向蛋白质进行降解来调节JAK/STAT信号.
研究的目的:
- 研究Cullin 5 (CUL5) 在调节造血干细胞 (HSC) 功能和命运决策中的作用.
- 阐明CUL5影响HSC增殖,分化和信号通路的分子机制.
主要方法:
- 在造血细胞中产生CUL5缺乏的小鼠 (Cul5Vav-Cre).
- 血液造血干细胞和原始细胞 (HSPC) 数量,分化偏差和HSC增殖的分析.
- 同免疫沉用于识别CUL5相互作用蛋白,包括LRRC41.
- 对HSPC的蛋白质组分析以确定CUL5受调节的基因和通路.
- 使用ruxolitinib进行JAK1/2抑制以评估治疗潜力.
主要成果:
- Cul5Vav-Cre小鼠表现出增加的HSPCs,脊髓巨变和外骨髓造血.
- 差异化偏向于髓状细胞和巨核细胞系,导致白细胞症,贫血和血栓细胞症.
- 由于CUL5缺乏,HSC的扩散和循环增加,CXCR4的表达减少.
- 鉴定出LRRC41是一种CUL5相互作用蛋白,在IL-3刺激后,在Cul5Vav-Cre HSC中观察到它与STAT5的积累.
- 蛋白质组分析显示,在Cul5Vav-Cre HSPCs中,STAT5目标基因的上调.
- 在Cul5Vav-Cre小鼠中,ruxolitinib治疗使血液形成正常化.
结论:
- CUL5在维持HSC功能和调节干细胞命运决策方面发挥着至关重要的作用.
- CUL5调节IL-3信号通路,可能通过其与LRRC41的相互作用和STAT5.5的控制来调节.
- 用鲁克索利提尼布准JAK1/2可以纠正由CUL5缺乏引起的异常造血.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K


